戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 loped countries and reported outcomes (e.g., retention in care).
2  treatment outcomes, and efforts to increase retention in care.
3 utcomes included adverse events, deaths, and retention in care.
4 r identifying populations in need of greater retention in care.
5 IV acquisition and barriers to access to and retention in care.
6 ent-level factors associated with successful retention in care.
7 esting outcome, and being unable to evaluate retention in care.
8 of providing ART at diagnosis: its impact on retention in care.
9 aternal ART initiation and mother and infant retention in care.
10 as no evidence of an effect on engagement or retention in care.
11 logical failure, immunological response, and retention in care.
12  at diagnosis may help to remove barriers to retention in care.
13 tion, and suboptimal quality of services and retention in care.
14 treatment initiation is associated with poor retention in care.
15  with regard to diagnosis and linkage to and retention in care.
16 urdens on patients and providers and improve retention in care.
17 otential barriers that may impact access and retention in care.
18               The primary study endpoint was retention in care 12 months after HIV testing with HIV-1
19 re significantly less likely to have optimal retention in care (adjusted odds ratio [aOR] 0.65, CI =
20 he role of voucher incentives on linkage and retention in care among DUs in India.
21 regression discontinuity design, we assessed retention in care among patients starting HIV treatment
22 f the factors in the pathway for entry to or retention in care among people living with HIV.
23 en gender (cisgender or transgender) and (1) retention in care and (2) viral suppression using 2016 c
24 uum, from testing and diagnosis to long-term retention in care and anti-retroviral therapy adherence.
25 d recommendations to optimize entry into and retention in care and ART adherence for people with HIV.
26 cumented Hispanics achieved similar rates of retention in care and HIV suppression as documented Hisp
27 care and enhance social support may increase retention in care and improve clinical health.
28 e intervention efforts are needed to improve retention in care and medication adherence so that more
29 D models in South Africa had slightly better retention in care and similar viral suppression to those
30                    Our primary outcomes were retention in care and viral suppression (<50 copies per
31   The objective of this study was to examine retention in care and viral suppression among transgende
32 lines on time to ART initiation and rates of retention in care and viral suppression at 1 year in the
33 from cohort enrolment to ART initiation, and retention in care and viral suppression at 6 and 12 mont
34 olutegravir use and the outcomes of 12-month retention in care and viral suppression at less than 50
35  compare the outcomes of subsequent 12-month retention in care and viral suppression between people w
36 eriod, we estimated the risk differences for retention in care and viral suppression by comparing tho
37 centives delivered using mHealth can improve retention in care and viral suppression in adults starti
38             We evaluated factors influencing retention in care and viral suppression in postpartum HI
39 t implemented share-the-care practices, only retention in care and viral suppression outcomes improve
40         Further research should assess their retention in care and viral suppression under Treat All.
41 V care, frequency of outpatient care visits, retention in care and viral suppression.
42                                Outcomes were retention in care and viral suppression.
43 tment initiation, while maintaining rates of retention in care and viral suppression.
44 n prespecified secondary outcomes, including retention in care and VL change.
45 tegies to expand provision of MOUD, increase retention in care, and address co-occurring physical and
46 e backbone of HIV prevention, treatment, and retention in care, and are central to the achievement of
47 f early diagnosis and treatment, linkage and retention in care, and care engagement at the time of ho
48 ve case finding, diagnosis, linkage to care, retention in care, and post-treatment monitoring of TB p
49 d can achieve levels of same-day ART uptake, retention in care, and viral suppression among incarcera
50 Targets were missed for on-time pill pickup, retention in care, and virological suppression.
51 elling models, task shifting, linkage to and retention in care, antiretroviral therapy support, behav
52                          Core indicators for retention in care are calculated based on attended HIV c
53             Antiretroviral therapy (ART) and retention in care are essential for the prevention of mo
54 that improve not just HIV screening but also retention in care are needed to optimize epidemiologic i
55 es are recommended to improve linkage to and retention in care are provided.
56                     Interventions to improve retention in care are resource intensive, and there is c
57 tcome of linkage to care within 1 month plus retention in care at 12 months after HIV-positive testin
58 nkage (2.5 days versus 7.5 days, p = 0.189), retention in care at 12 months regardless of time to lin
59                   Viral suppression (VS) and retention in care at 12 months were compared via intenti
60                      The primary outcome was retention in care at 12 months, defined as the proportio
61          After adjusting for clustering, for retention in care at 12 months, the 6-monthly ART dispen
62  next scheduled encounter) in all groups and retention in care at 15 months in group 1 and group 4 by
63                   Outcomes assessed included retention in care at 6 weeks' post partum and uptake of
64 days and (2) ART initiation in <=28 days and retention in care at 8 months (composite outcome).
65 sed rates of infant HIV testing and maternal retention in care at both intervention and control facil
66 ilities across three provinces and estimated retention in care (attended facility visit within 12 mon
67                      The coprimary outcomes, retention in care (attending a clinic within the last 6
68      The pooled adjusted risk difference for retention in care between clients enrolled in DSD and th
69 reening, linkage, and particularly improving retention in care, can substantially reduce the burden o
70 (HIV)-infected patients across time improves retention in care compared with existing standard of car
71 tality and RHD care quality metrics (such as retention in care) compared to those with RHD alone sugg
72       The primary outcome was a composite of retention in care (completed HIV primary care visits wit
73  Caution is warranted in relying solely upon retention in care core indicators for policy, clinical,
74 y rates of HIV testing, linkage to care, and retention in care documented from health facility record
75 utcomes were infant HIV testing and maternal retention in care during the first 8 weeks after deliver
76 the control group met the primary outcome of retention in care during the first 8 weeks after deliver
77                                              Retention in care for human immunodeficiency virus (HIV)
78 regimens and improved regimen assignment and retention in care for patients with rifampicin-resistant
79 suboptimal rates of testing, engagement, and retention in care for people who inject drugs (PWID) in
80 s, and hypertension led to improved rates of retention in care for people with diabetes or hypertensi
81         Simplified drug regimens may improve retention in care for persons with chronic diseases.
82 tential solution to LTFU which could improve retention in care for women living with HIV.
83 within 90 days of delivery), associated with retention in care (&gt;/= 1 CD4 count or VL test in each 6-
84                Both approaches achieved high retention in care (&gt;97%) and viral suppression rates (>9
85 hotherapy, and pharmacologic treatments, and retention in care in clinical community-based, pediatric
86 ticipants with a missing viral load, lack of retention in care in the on-site ART programme) at 6 mon
87 sualizing deficiencies in case detection and retention in care, in order to prioritize interventions.
88                    Support for adherence and retention in care, individualized risk assessment and co
89 s are provided for monitoring entry into and retention in care, interventions to improve entry and re
90                                              Retention in care is an essential component of meeting t
91 on <=28 days and 2) initiation <=28 days and retention in care &lt;=8 months of enrollment.
92 ing that routine program data underestimated retention in care markedly.
93 re associated with ART initiation, including retention in care monitoring and medication dispensing r
94 re associated with ART initiation, including retention in care monitoring and medication dispensing r
95 mizing services to facilitate engagement and retention in care of people living with HIV (PLWH) on an
96  increased HIV testing, linkage to care, and retention in care over time in intervention relative to
97            Our study suggests that improving retention in care-possibly by decentralizing RHD service
98 Health Resources and Services Administration Retention in Care project.
99               The main outcome measures were retention in care (quarter years with at least one compl
100                                              Retention in care (RIC) leads to reduced HIV transmissio
101 ion between different RW service classes and retention in care (RiC) or viral suppression (VS).
102 ssed treatment adherence, viral suppression, retention in care, stigma, depressive symptoms, and qual
103 ferrals after testing positive, and improved retention in care strategies are required to further red
104 sign to examine the rates of ART initiation, retention in care, time to ART initiation, and first-lin
105 itiation of ART </=90 d of study enrollment, retention in care, time to ART initiation, patient-level
106 with HIV infection, effective linkage to and retention in care, timely initiation of ART, and high le
107 ince linkage with respect to ART initiation, retention in care, transfers, and mortality.
108 effect of immediate (versus deferred) ART on retention in care using a regression discontinuity desig
109 roviral therapy (ART) delivery would improve retention in care, viral load suppression, and change in
110                                              Retention in care was assessed for persons initiating Pr
111 sity score matched people, the likelihood of retention in care was higher among the dolutegravir grou
112           Compared with AZT/XTC/LPV/r (75%), retention in care was higher with AZT/XTC/DTG (86%, adju
113                                     Observed retention in care was lower with TDF/XTC/DTG than with A
114                                              Retention in care was measured by the IOM and DHHS core
115                                              Retention in care was observed in more than 95% of the p
116                                              Retention in care was similar for cohorts starting in 20
117                                              Retention in care was the most significant barrier to ac
118                                 Estimates of retention in care were consistently lower in TW, with li
119 c initiatives to improve maternal and infant retention in care were ongoing at all facilities at the
120 her means in order to optimize adherence and retention in care, whenever necessary.
121  face significant barriers to linkage to and retention in care which impede the necessary steps towar
122                      The primary outcome was retention in care with 48-week HIV-1 RNA <200 copies/mL,
123 ssion [VLS; viral load <1000 copies per mL], retention in care with non-suppressed viral load [NVL; v
124 ness, mortality, and HIV treatment outcomes (retention in care with viral load suppression [VLS; vira
125          We evaluated the primary outcome of retention in care with viral suppression (<1000 copies p
126 d beneficial in this setting, as it improves retention in care with virologic suppression among patie

 
Page Top